342 related articles for article (PubMed ID: 8333804)
1. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1993 Jul; 153(14):1665-70. PubMed ID: 8333804
[TBL] [Abstract][Full Text] [Related]
2. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
3. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
[TBL] [Abstract][Full Text] [Related]
4. Peptic ulcer and gastrointestinal hemorrhage associated with nonsteroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study.
Lanza LL; Walker AM; Bortnichak EA; Dreyer NA
Arch Intern Med; 1995 Jul; 155(13):1371-7. PubMed ID: 7794085
[TBL] [Abstract][Full Text] [Related]
5. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
[TBL] [Abstract][Full Text] [Related]
6. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
7. 30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: a population-based study.
Thomsen RW; Riis A; Munk EM; Nørgaard M; Christensen S; Sørensen HT
Am J Gastroenterol; 2006 Dec; 101(12):2704-10. PubMed ID: 17026569
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK; Castellsague J; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
[TBL] [Abstract][Full Text] [Related]
9. Drugs and ulcers: clues about mucosal protection from epidemiologic studies.
Griffin MR; Smalley WE
J Clin Gastroenterol; 1995; 21 Suppl 1():S113-9. PubMed ID: 8775002
[TBL] [Abstract][Full Text] [Related]
10. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study.
Vonkeman HE; Fernandes RW; van der Palen J; van Roon EN; van de Laar MA
Arthritis Res Ther; 2007; 9(3):R52. PubMed ID: 17521422
[TBL] [Abstract][Full Text] [Related]
11. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
12. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
14. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons.
Smalley WE; Ray WA; Daugherty JR; Griffin MR
Am J Epidemiol; 1995 Mar; 141(6):539-45. PubMed ID: 7900721
[TBL] [Abstract][Full Text] [Related]
16. Exposure to nonsteroidal anti-inflammatory drugs among older adult patients hospitalized for peptic ulcer disease in Argentina: A case-control study.
Insúa J; Mavros P; Hunsche E; Kong S; Tibaudin-Agver O
Am J Geriatr Pharmacother; 2006 Sep; 4(3):251-9. PubMed ID: 17062326
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly.
Beard K; Walker AM; Perera DR; Jick H
Arch Intern Med; 1987 Sep; 147(9):1621-3. PubMed ID: 3498451
[TBL] [Abstract][Full Text] [Related]
18. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
19. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs.
Peoples JB
Am Surg; 1985 Jun; 51(6):358-62. PubMed ID: 3994179
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]